Nifty
:
22147.00
Sensex
:
73088.33
151.15 (0.69%)
599.34 (0.83%)
Nifty
Sensex
:
:
22147.00
73088.33
151.15 (0.69%)
599.34 (0.83%)

Lincoln Pharmaceuticals Ltd.

Pharmaceuticals & Drugs - Global

Rating :
60/99

BSE: 531633 | NSE: LINCOLN

NSE BSE
582.10
19-Apr-2024
  • Open
  • High
  • Low
  • Previous Close
  •  572.10
  •  589.00
  •  565.10
  •  579.90
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  41688
  •  240.93
  •  755.15
  •  365.25

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 1,161.82
  • 13.31
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 1,124.26
  • 0.26%
  • 2.02

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 49.53%
  • 1.78%
  • 37.36%
  • FII
  • DII
  • Others
  • 3.93%
  • 0.00%
  • 7.40%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 9.26
  • 6.86
  • 6.35

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 16.09
  • 5.82
  • 0.46

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 21.21
  • 8.40
  • 5.41

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 10.20
  • 9.01
  • 10.54

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 1.70
  • 1.51
  • 1.70

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 7.07
  • 6.39
  • 7.16

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Dec 23
Dec 22
Var%
Sep 23
Sep 22
Var%
Jun 23
Jun 22
Var%
Mar 23
Mar 22
Var%
Net Sales
146.45
133.77
9.48%
155.99
140.61
10.94%
135.62
123.47
9.84%
112.46
102.59
9.62%
Expenses
116.79
107.01
9.14%
124.84
111.71
11.75%
114.90
106.56
7.83%
95.82
85.14
12.54%
EBITDA
29.66
26.75
10.88%
31.15
28.90
7.79%
20.72
16.91
22.53%
16.64
17.45
-4.64%
EBIDTM
20.25%
20.00%
19.97%
20.55%
15.28%
13.70%
14.80%
17.01%
Other Income
11.02
6.36
73.27%
8.70
5.72
52.10%
7.69
6.50
18.31%
3.90
1.89
106.35%
Interest
0.16
0.33
-51.52%
0.39
0.14
178.57%
0.42
0.41
2.44%
1.15
0.57
101.75%
Depreciation
2.81
2.26
24.34%
2.58
2.42
6.61%
2.54
2.07
22.71%
2.41
2.00
20.50%
PBT
37.71
30.52
23.56%
36.87
32.06
15.00%
25.45
20.93
21.60%
16.98
16.77
1.25%
Tax
9.67
8.90
8.65%
9.21
8.35
10.30%
6.43
5.91
8.80%
4.42
5.75
-23.13%
PAT
28.04
21.61
29.75%
27.65
23.71
16.62%
19.01
15.01
26.65%
12.56
11.03
13.87%
PATM
19.15%
16.16%
17.73%
16.86%
14.02%
12.16%
11.17%
10.75%
EPS
14.00
10.79
29.75%
13.81
11.84
16.64%
9.49
7.49
26.70%
6.27
5.50
14.00%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Net Sales
550.52
510.31
472.12
424.19
386.49
366.15
360.61
360.26
400.15
266.07
210.49
Net Sales Growth
10.01%
8.09%
11.30%
9.75%
5.56%
1.54%
0.10%
-9.97%
50.39%
26.41%
 
Cost Of Goods Sold
253.26
179.43
169.71
155.86
138.15
135.66
156.44
202.90
254.64
161.12
123.72
Gross Profit
297.26
330.88
302.41
268.32
248.34
230.49
204.18
157.35
145.50
104.96
86.77
GP Margin
54.00%
64.84%
64.05%
63.25%
64.26%
62.95%
56.62%
43.68%
36.36%
39.45%
41.22%
Total Expenditure
452.35
421.11
376.64
337.01
320.95
298.91
308.30
313.52
359.62
240.47
190.42
Power & Fuel Cost
-
10.25
8.33
7.10
8.18
7.21
6.82
5.92
5.68
4.27
3.40
% Of Sales
-
2.01%
1.76%
1.67%
2.12%
1.97%
1.89%
1.64%
1.42%
1.60%
1.62%
Employee Cost
-
93.16
79.72
63.26
58.65
51.90
51.15
37.59
28.83
17.87
18.57
% Of Sales
-
18.26%
16.89%
14.91%
15.18%
14.17%
14.18%
10.43%
7.20%
6.72%
8.82%
Manufacturing Exp.
-
85.72
69.33
61.54
64.05
60.71
51.73
29.44
35.81
25.98
19.10
% Of Sales
-
16.80%
14.68%
14.51%
16.57%
16.58%
14.35%
8.17%
8.95%
9.76%
9.07%
General & Admin Exp.
-
31.06
27.56
23.06
21.30
20.98
17.50
14.78
20.34
18.86
15.07
% Of Sales
-
6.09%
5.84%
5.44%
5.51%
5.73%
4.85%
4.10%
5.08%
7.09%
7.16%
Selling & Distn. Exp.
-
19.20
19.49
24.54
26.79
20.02
21.24
19.91
10.10
9.42
8.42
% Of Sales
-
3.76%
4.13%
5.79%
6.93%
5.47%
5.89%
5.53%
2.52%
3.54%
4.00%
Miscellaneous Exp.
-
2.28
2.51
1.64
3.83
2.43
3.44
2.97
4.22
2.95
8.42
% Of Sales
-
0.45%
0.53%
0.39%
0.99%
0.66%
0.95%
0.82%
1.05%
1.11%
1.01%
EBITDA
98.17
89.20
95.48
87.18
65.54
67.24
52.31
46.74
40.53
25.60
20.07
EBITDA Margin
17.83%
17.48%
20.22%
20.55%
16.96%
18.36%
14.51%
12.97%
10.13%
9.62%
9.53%
Other Income
31.31
22.47
10.00
5.66
11.04
5.63
5.45
2.78
7.36
7.19
2.49
Interest
2.12
2.03
1.45
1.56
2.02
4.00
5.41
6.66
9.96
8.38
6.97
Depreciation
10.34
9.17
8.09
7.56
7.33
6.68
6.11
5.51
4.87
4.57
3.53
PBT
117.01
100.48
95.94
83.72
67.23
62.19
46.25
37.33
33.07
19.85
12.07
Tax
29.73
27.58
26.58
21.47
15.77
13.46
11.60
9.20
9.27
4.80
1.89
Tax Rate
25.41%
27.45%
27.70%
25.65%
23.46%
21.64%
25.08%
24.65%
28.03%
24.18%
15.66%
PAT
87.26
72.90
69.36
62.25
51.44
48.71
34.62
28.12
23.68
15.01
10.65
PAT before Minority Interest
87.26
72.90
69.36
62.25
51.47
48.74
34.65
28.13
23.80
15.04
10.18
Minority Interest
0.00
0.00
0.00
0.00
-0.03
-0.03
-0.03
-0.01
-0.12
-0.03
0.47
PAT Margin
15.85%
14.29%
14.69%
14.68%
13.31%
13.30%
9.60%
7.81%
5.92%
5.64%
5.06%
PAT Growth
22.28%
5.10%
11.42%
21.01%
5.60%
40.70%
23.12%
18.75%
57.76%
40.94%
 
EPS
43.63
36.45
34.68
31.13
25.72
24.36
17.31
14.06
11.84
7.51
5.33

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Shareholder's Funds
502.47
432.88
366.39
313.09
269.34
224.22
192.38
140.52
111.31
98.81
Share Capital
20.03
20.03
20.03
20.00
20.00
20.00
20.00
16.31
16.31
16.31
Total Reserves
482.44
412.85
346.36
293.09
249.34
204.22
172.38
116.65
95.00
82.50
Non-Current Liabilities
37.88
10.99
26.10
42.85
28.43
24.94
31.75
33.74
33.14
26.18
Secured Loans
0.00
0.00
0.14
0.85
1.69
6.93
12.38
23.62
15.27
16.20
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
10.21
3.04
Long Term Provisions
25.22
0.00
15.98
32.51
17.49
7.19
9.98
0.00
0.00
0.00
Current Liabilities
96.15
110.71
94.78
80.32
100.37
113.48
99.42
100.34
114.47
131.05
Trade Payables
51.15
71.67
57.07
51.24
44.01
43.42
32.46
30.38
45.31
66.51
Other Current Liabilities
14.22
9.84
13.43
9.13
11.11
11.11
12.77
15.10
11.52
14.15
Short Term Borrowings
2.00
2.04
0.00
3.83
30.09
48.55
45.04
52.62
50.67
48.46
Short Term Provisions
28.78
27.16
24.28
16.11
15.16
10.41
9.15
2.24
6.97
1.92
Total Liabilities
636.50
554.58
487.27
436.64
398.50
362.97
323.85
274.79
261.85
259.75
Net Block
150.53
131.88
110.64
122.72
120.91
116.58
102.71
98.47
65.62
65.07
Gross Block
197.47
171.07
141.90
146.70
138.11
127.65
108.16
120.89
87.50
82.22
Accumulated Depreciation
46.95
39.19
31.26
23.98
17.21
11.08
5.45
22.42
21.88
17.15
Non Current Assets
245.42
181.51
159.59
173.91
159.43
136.08
134.27
127.83
80.64
110.69
Capital Work in Progress
6.71
16.05
1.69
0.04
2.10
0.29
6.63
2.73
2.55
2.37
Non Current Investment
0.00
0.00
0.00
0.09
0.09
0.09
0.09
0.01
0.01
0.41
Long Term Loans & Adv.
87.71
31.83
46.81
51.02
36.01
18.79
24.48
26.62
12.47
42.84
Other Non Current Assets
0.47
1.75
0.45
0.03
0.33
0.34
0.36
0.00
0.00
0.00
Current Assets
391.08
373.07
327.69
262.73
239.08
226.88
189.58
146.98
181.20
149.06
Current Investments
91.33
96.81
80.66
34.22
18.07
10.97
10.25
0.00
0.00
0.00
Inventories
70.03
72.74
46.61
47.40
36.23
45.41
37.31
27.48
21.82
23.84
Sundry Debtors
136.33
115.94
113.35
101.34
122.47
109.44
90.67
80.53
119.01
89.04
Cash & Bank
34.32
18.80
13.84
14.58
7.58
14.59
11.68
12.66
11.51
10.45
Other Current Assets
59.08
1.19
1.43
1.11
54.74
46.47
39.68
26.31
28.86
25.73
Short Term Loans & Adv.
56.98
67.59
71.79
64.09
53.64
45.18
39.02
26.26
28.86
25.73
Net Current Assets
294.93
262.36
232.91
182.41
138.71
113.40
90.16
46.63
66.73
18.01
Total Assets
636.50
554.58
487.28
436.64
398.51
362.96
323.85
274.81
261.84
259.75

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Cash From Operating Activity
39.26
76.13
69.27
75.42
52.84
26.63
25.04
44.80
24.56
4.64
PBT
100.48
95.94
83.72
67.23
62.19
46.25
37.33
33.07
19.85
12.07
Adjustment
-0.23
1.48
4.84
8.66
9.30
11.64
10.70
13.75
10.68
12.75
Changes in Working Capital
-31.37
2.40
0.20
14.33
-1.12
-22.00
-13.24
4.80
-2.50
-17.56
Cash after chg. in Working capital
68.87
99.83
88.76
90.22
70.38
35.88
34.79
51.62
28.02
7.26
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-29.61
-23.70
-19.49
-14.81
-17.53
-9.25
-9.75
-6.82
-3.46
-2.62
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-36.64
-78.08
-64.23
-30.88
-18.19
-11.77
-25.48
-41.79
6.52
1.45
Net Fixed Assets
-17.06
-43.53
-35.54
-5.59
-11.52
-12.45
4.05
-29.04
-4.21
-0.95
Net Investments
5.48
-16.15
-20.70
-14.20
-7.10
-2.72
-16.01
-7.34
-1.43
0.00
Others
-25.06
-18.40
-7.99
-11.09
0.43
3.40
-13.52
-5.41
12.16
2.40
Cash from Financing Activity
-4.50
-2.56
-5.75
-37.76
-35.77
-11.41
0.30
-3.42
-32.04
-10.51
Net Cash Inflow / Outflow
-1.88
-4.50
-0.70
6.77
-1.11
3.45
-0.14
-0.41
-0.96
-4.42
Opening Cash & Equivalents
6.93
11.44
12.14
5.46
6.57
3.12
3.26
3.75
4.82
9.39
Closing Cash & Equivalent
5.05
6.93
11.44
12.23
5.46
6.57
3.12
3.43
3.87
4.97

Financial Ratios

Consolidated /

Standalone
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Book Value (Rs.)
250.86
216.12
182.92
156.54
134.67
112.11
96.19
81.52
68.24
60.58
ROA
12.24%
13.31%
13.48%
12.33%
12.80%
10.09%
9.40%
8.87%
5.77%
4.10%
ROE
15.59%
17.35%
18.32%
17.67%
19.75%
16.63%
17.29%
19.49%
14.32%
10.83%
ROCE
21.82%
24.29%
24.90%
22.30%
22.50%
19.05%
18.51%
21.18%
15.91%
11.48%
Fixed Asset Turnover
2.89
3.17
3.04
2.81
2.84
3.07
3.19
3.90
3.20
2.67
Receivable days
86.41
84.27
89.34
102.22
112.23
100.99
85.52
89.69
139.97
139.16
Inventory Days
48.90
43.86
39.12
38.19
39.51
41.74
32.36
22.16
30.72
36.67
Payable days
124.92
138.44
126.82
56.60
57.26
47.62
37.21
40.22
92.31
115.76
Cash Conversion Cycle
10.40
-10.30
1.64
83.82
94.48
95.11
80.67
71.63
78.37
60.06
Total Debt/Equity
0.00
0.00
0.00
0.02
0.12
0.27
0.34
0.59
0.69
0.69
Interest Cover
50.50
67.11
54.61
34.32
16.56
9.55
6.60
4.32
3.37
2.73

Annual Reports:

FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017
FY 2016
FY 2015
FY 2014

News Update:


  • Lincoln Pharma - Quarterly Results
    8th Feb 2024, 12:28 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.